Codi Co., Ltd. (224060)

Overview

THE CODI Co.,LTD., originally established in 1999 and formerly known as CODI-M Co., LTD., underwent a name change in November 2022. Situated in Cheonan-si, South Korea, THE CODI Co.,LTD. is a key player in the manufacturing and sales of semiconductor and display equipment, along with exposure equipment. Moreover, the company has expanded its horizon into the bio-healthcare sector, actively engaging in the development of various therapeutic agents and immunotherapies aimed at addressing a spectrum of diseases including Zika/MERS, glaucoma, non-alcoholic fatty liver disease, chronic kidney diseases, cancer, and inflammatory diseases.

Products and Services

• Semiconductor and Display Equipment

  THE CODI Co.,LTD. provides cutting-edge equipment essential for the production of semiconductors and displays. This includes technology aimed at enhancing the efficiency and reliability of semiconductor chips and display panels.

• Exposure Equipment

  A critical tool in the manufacturing of semiconductors, the exposure equipment offered by THE CODI Co.,LTD. plays a vital role in the lithography process, enabling precise patterning essential for the miniaturization and complexity of semiconductor circuits.

• Bio-Healthcare Products

  Engaging in the biotechnology and healthcare sectors, THE CODI Co.,LTD. is at the forefront of developing therapeutic agents and treatments for a wide range of diseases. The company's efforts include:

  • Therapeutic Agent Development

    THE CODI Co.,LTD. is working on innovative therapies for diseases such as Zika/MERS, glaucoma, non-alcoholic fatty liver disease, and chronic kidney diseases, targeting specific unmet medical needs.

  • Immunotherapy

    With a focus on cancer and inflammatory diseases, the company is also pioneering in the realm of immunotherapy. The goal is to harness the body's immune system to fight off these diseases, presenting new paradigms in treatment methods.